ATTO (Attovia Therapeutics) Days Sales Outstanding: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATTO Attovia Therapeutics Inc ATTO
8 GF Score
Price $22.11
! 1 Warning Sign
View Full Analysis

What is Attovia Therapeutics Days Sales Outstanding?

Attovia Therapeutics's average Accounts Receivable for the three months ended in Jun. 2026 was $0.00 Mil. Attovia Therapeutics's Revenue for the three months ended in Jun. 2026 was $0.45 Mil. Hence, Attovia Therapeutics's Days Sales Outstanding for the three months ended in Jun. 2026 was 0.00.

The historical rank and industry rank for Attovia Therapeutics's Days Sales Outstanding or its related term are showing as below:

ATTO's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 68.98
* Ranked among companies with meaningful Days Sales Outstanding only.

Attovia Therapeutics's Days Sales Outstanding stayed the same from . 20 (0.00) to Jun. 2026 ().

Attovia Therapeutics  (NAS:ATTO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Attovia Therapeutics Days Sales Outstanding Related Terms

Attovia Therapeutics Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Attovia Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Attovia Therapeutics Days Sales Outstanding Chart

Attovia Therapeutics Annual Data
Trend Dec24 Dec25
Days Sales Outstanding
- -

Attovia Therapeutics Quarterly Data
Mar25 Jun25 Mar26 Jun26
Days Sales Outstanding - - - -

ATTO vs TBPH, ACRS, OLMA: Days Sales Outstanding Comparison

For the Biotechnology subindustry, Attovia Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Attovia Therapeutics Days Sales Outstanding vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Attovia Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Attovia Therapeutics's Days Sales Outstanding falls into.


ATTO
8GF Score
Attovia Therapeutics Inc ATTO
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Attovia Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Attovia Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2025 is calculated as

Days Sales Outstanding (A: Dec. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count ) / Revenue (A: Dec. 2025 )*Days in Period
=( ( + ) / 1 ) / 1.35*365
=0 / 1.35*365
=0.00

Attovia Therapeutics's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding (Q: Jun. 2026 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2026 ) + Accounts Receivable (A: Jun. 2026 )) / count ) / Revenue (A: Jun. 2026 )*Days in Period
=( ( + ) / 1 ) / 0.45*365 / 4
=0 / 0.45*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Attovia Therapeutics Business Description

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
8GF Score

Get the complete analysis for ATTO

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.11
Price